Wu, Xiangwei

TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation

Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., et al. (2009) · Nature Medicine

Bone Metabolism and DiseasesTGF-β signaling in diseases

Cited by 1,165

Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells

Xian, L., Wu, X., Pang, L., Lou, M., Rosen, C. J., Qiu, T., Crane, J., Frassica, F., Zhang, L., Rodriguez, J. P., et al. (2012) · Nature Medicine

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 631

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

Shen, J., Peng, Y., Wei, L., Zhang, W., Yang, L., Lan, L., Kapoor, P., Ju, Z., Mo, Q., Shih, I.-M., et al. (2015) · Cancer Discovery

Chromatin Remodeling and CancerPARP inhibition in cancer therapy

Cited by 522

Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities

Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology

Cancer-related Molecular PathwaysSignaling Pathways in Disease

Cited by 111

Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma

Zhou, L., Wang, M., Guo, H., Hou, J., Zhang, Y., Li, M., Wu, X., Chen, X., & Wang, L. (2022) · Frontiers in Immunology

Immune cells in cancerCancer Immunotherapy and Biomarkers

Cited by 85